Pattern-recognition receptor activation and signaling remain the predominant inducer for IFN signatures that can protect as well as portend onset of not only T1D, but are also typical of rheumatic disorders such as SLE and RA (68, 69). This evidence concerns the gene IFNA1 and type 1 diabetes mellitus.